DEXAPOLYCID

  • Therapeutic Category
    • ANTI-INFLAMMATORY AGENTS
    • ANTI-INFECTIVE AGENTS
    • OPHTHALMOLOGICAL DRUGS
  • Pharmaceutical Form : Eye Drops
  • Composition : Polymyxin B Sulphate 7500 IU + Neomycin Sulphate 5 mg + Dexamethasone Sod. Phose. 1.32 mg + Gramicidin 0.02 mg/ 1 ml
  • Active Substance : Polymyxin B Sulphate+Neomycin Sulphate+Dexamethasone Sod. Phose.+Gramicidin

Properties : 

Dexapolycid  contains  four  effective  anti  inflammatory

Ingredients :

*  Polymyxin  B   and  Neomycin   offer   a broad – spectrum  antibiotics effectiveness against gram-negative and gram-positive bacteria .

Polymyxin B is more active against pseudomonas pyocyanea .

* Gramicidin : is an active antibiotic for wide spectrum of gram-positive bacteria  except  bacilli  and  gram-negative bacteria especially neisseria

* Dexamethasone  Sodium  Phosphate :  is  a steroid substance helps in The treatment of many inflammatory eye lesions .

Indications :

Dexapolycid is used in the following cases :

* Postoperatively as a prophylactic treatment .

* Treatment  of  infective  ocular  inflammation  produced by organisms which are sensitive to Neomycin – Gramicidin – Polymyxin B .

*Treatment of chronic and acute inflammations such as :

– Non purulent conjunctivitis     – Blepharoconjunctivitis

– Keratoconjunctivitis                – Non specific superficial keratitis

– Iridocyclitis                 – Acute iritis

– Kerato ulcer                – Blepharitis

– Scleroconjunctivitis and non purulent scleritis .

Contraindications :

Dexapolycid  do  not  use  in  the following cases :

* Fungal  and  tuberculous  eye lesions and  many viral  lesions ( herpes Simplex / dendritic keratitis ) .

* Vaccinia .                    * Varicella .

* Acute purulent conjunctivitis and acute purulent blepharitis .

* Hypersensitivity to any of its components .

Precautions :

* Extended  use  of  topical  therapy may cause increased intra-ocular  pressure  in  certain  individuals  which should be checked Frequently during therapy period .

* Prolonged   use   of  topical  steroids  may  produce  to  perforation  of cornea .

* Prolonged   use   may   result  overgrowth  non-susceptible  organisms including fungi .

* If any sensitive reactions appear, discontinue therapy .

Dosage & Administration :

Ophthalmic drops  :  instill  (1-2) drops in the conjunctival sac (4-6) times daily .

Ophthalmic  ointment :  Apply  small amount into the conjunctival sac

(3-4) times daily, may be used adjunctively with drops at bed time .

the  dosage  may be  decrease after 3-4 days when any favorable reasons obtained .

Packaging : * Ophthalmic Drops : bottle 10 ml.

                    * Ophthalmic Oint.  : tube 5 g.